BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36994552)

  • 1. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
    Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
    Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
    Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
    Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
    Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
    Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
    Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
    Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
    Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
    Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
    Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
    Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
    Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients.
    Zhao M; Li Q; Yang J; Zhang M; Liu X; Zhang H; Huang Y; Li J; Bao J; Wang J; Du J; Guan T; Su L
    Front Genet; 2023; 14():1066808. PubMed ID: 37152994
    [No Abstract]   [Full Text] [Related]  

  • 11. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
    Muntañola A; Mozas P; Mercadal S; Huguet M; Bobillo S; Bastos-Oreiro M; Jiménez-Ubieto A; Rovira J; Rivero A; Tolosa C; Luizaga L; de Villambrosia SG; Novelli S; Caballero D; Salar A; Alonso-Álvarez S; Magnano L; Gutiérrez NC; Sancho JM; López-Guillermo A;
    Br J Haematol; 2023 Feb; 200(3):306-314. PubMed ID: 36261137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
    Michot JM; Quivoron C; Sarkozy C; Danu A; Lazarovici J; Saleh K; El-Dakdouki Y; Goldschmidt V; Bigenwald C; Dragani M; Bahleda R; Baldini C; Arfi-Rouche J; Martin-Romano P; Tselikas L; Gazzah A; Hollebecque A; Lacroix L; Ghez D; Vergé V; Marzac C; Cotteret S; Rahali W; Soria JC; Massard C; Bernard OA; Dartigues P; Camara-Clayette V; Ribrag V
    Am J Hematol; 2023 Apr; 98(4):645-657. PubMed ID: 36606708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
    Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
    Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
    Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
    Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of follicular lymphoma.
    Takata K; Miyata-Takata T; Sato Y; Yoshino T
    J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort.
    Oishi N; Segawa T; Miyake K; Mochizuki K; Kondo T
    Histopathology; 2022 Apr; 80(5):820-826. PubMed ID: 35038193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
    Los-de Vries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
    Blood Adv; 2022 Sep; 6(18):5482-5493. PubMed ID: 35816682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.
    Péricart S; Waysse C; Siegfried A; Struski S; Delabesse E; Laurent C; Evrard S
    Virchows Arch; 2020 Apr; 476(4):609-614. PubMed ID: 31807922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.
    Laurent C; Adélaïde J; Guille A; Tesson B; Gat E; Evrard S; Escudié F; Syrykh C; Canioni D; Fabiani B; Meignin V; Chassagne-Clement C; Dartigues P; Traverse-Glehen A; Parrens M; Huet S; Copie-Bergman C; Salles G; Birnbaum D; Brousset P; Morschhauser F; Xerri L;
    Am J Surg Pathol; 2021 Oct; 45(10):1324-1336. PubMed ID: 34334687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation.
    Trecourt A; Mauduit C; Szablewski V; Fontaine J; Balme B; Donzel M; Laurent C; Sesques P; Ghesquières H; Bachy E; Salles G; Emile JF; Chassagne-Clément C; Genestier L; Copie-Bergman C; Traverse-Glehen A
    Am J Surg Pathol; 2022 Jan; 46(1):58-70. PubMed ID: 34265801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.